Cargando…

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism

Recent studies suggest a link between pro-neurotensin (pro-NT) and nonalcoholic fatty liver disease (NAFLD), but the published data are conflicting. Thus, we aimed to analyze pro-NT levels in women with morbid obesity (MO) and NAFLD to investigate if this molecule is involved in NAFLD and liver lipi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villar, Beatriz, Bertran, Laia, Aguilar, Carmen, Binetti, Jessica, Martínez, Salomé, Sabench, Fàtima, Real, Monica, Riesco, David, París, Marta, Del Castillo, Daniel, Richart, Cristóbal, Auguet, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226510/ https://www.ncbi.nlm.nih.gov/pubmed/34200577 http://dx.doi.org/10.3390/metabo11060373

Ejemplares similares

Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis
por: Auguet, Teresa, et al.
Publicado: (2020)

Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

The Role of Olfactomedin 2 in the Adipose Tissue–Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2023)

The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2021)

Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD
por: Binetti, Jessica, et al.
Publicado: (2020)

Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
por: Bertran, Laia, et al.
Publicado: (2021)

Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity
por: Bertran, Laia, et al.
Publicado: (2022)

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2022)

Expression of Jejunal Taste Receptors in Women with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2021)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
por: Auguet, Teresa, et al.
Publicado: (2022)

LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus
por: Auguet, Teresa, et al.
Publicado: (2023)

Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology
por: Bertran, Laia, et al.
Publicado: (2022)

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women
por: Auguet, Teresa, et al.
Publicado: (2011)

Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2019)

Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Interleukin-17A Gene Expression in Morbidly Obese Women
por: Zapata-Gonzalez, Fernando, et al.
Publicado: (2015)

Clinical and Biomarker Profile Responses to Rehabilitation Treatment in Patients with Long COVID Characterized by Chronic Fatigue
por: Binetti, Jessica, et al.
Publicado: (2023)

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease
por: Mohamed, Amal A, et al.
Publicado: (2022)

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women
por: Guiu-Jurado, Esther, et al.
Publicado: (2015)

Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis
por: Cabré, Noemí, et al.
Publicado: (2022)

Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
por: Tincopa, Monica A.
Publicado: (2020)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2018)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome
por: Perpiñan, Carles, et al.
Publicado: (2022)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1p2ijh9cavk8t65gaamdbr0aqg